6472 — Bora Pharmaceuticals Co Balance Sheet
0.000.00%
- TWD70.60bn
- TWD85.80bn
- TWD19.25bn
- 47
- 20
- 94
- 56
Annual balance sheet for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 670 | 911 | 3,529 | 3,396 | 5,917 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 726 | 861 | 6,418 | 4,111 | 11,436 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,627 | 2,792 | 12,241 | 10,604 | 23,566 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,266 | 4,088 | 7,338 | 7,494 | 12,510 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 7,004 | 7,372 | 22,761 | 25,134 | 45,599 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,286 | 1,841 | 10,496 | 8,229 | 13,809 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,539 | 4,220 | 18,233 | 16,049 | 32,732 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,465 | 3,153 | 4,528 | 9,085 | 12,867 |
Total Liabilities & Shareholders' Equity | 7,004 | 7,372 | 22,761 | 25,134 | 45,599 |
Total Common Shares Outstanding |